Detailed explanation of the usage and dosage of everolimus, and what are the side effects?

Everolimus is an oral mTOR inhibitor produced by Novartis Pharmaceuticals. It is mainly used to treat various types of cancer, including hormone receptor-positive, HER2-negative breast cancer, neuroendocrine tumors, renal cell carcinoma, and tuberous sclerosis-related renal angiomyolipoma and subependymal giant cell astrocytoma.

For breast cancer, neuroendocrine tumors, renal cell carcinoma, and renal angiomyolipoma, the recommended dose of everolimus is10 mg orally once daily until disease progression or unacceptable toxicity occurs. For tuberous sclerosis-related subependymal giant cell astrocytoma and partial-onset epilepsy, the recommended starting dose is 4.5 mg/m² and 5 mg/m², respectively, taken orally once daily until disease progression or unacceptable toxicity.

Everolimus should be taken at the same time every day, either on an empty stomach or after a meal, but in the same way each time. Tablets should be swallowed whole and should not be chewed, crushed or dissolved.

If a dose of everolimus is missed, it may be given within 6 hours of your normal dose After more than 6 hours, the day's dose should be skipped. The next day, it should be taken at your normal time. Double doses should not be used to make up for a missed dose.

Everolimus may cause some side effects during treatment. Common side effects include fever, cough, infection, weakness, fatigue, mouth sores, nausea, loss of appetite, body swelling, rash, irregular menstruation, headache and high blood sugar. Among them, symptoms of high blood sugar may include increased thirst, increased urination, dry mouth, and fruity bad breath. For patients who develop hyperglycemia, blood glucose levels should be closely monitored and treatment plans adjusted if necessary.

In addition to the common side effects, everolimus can cause some serious side effects. For example, blisters or ulcers in the mouth, red and swollen gums, and difficulty swallowing may be symptoms of stomatitis. Lung problems, such as new or worsening cough, chest pain, wheezing, and shortness of breath, may also be among the side effects of everolimus. Infections, kidney problems, liver problems, low blood counts, and wounds that don't heal may also be serious side effects of everolimus.

Therefore, while taking everolimus, patients should closely monitor their physical condition. If any discomfort or abnormal symptoms occur, they should seek medical treatment promptly and inform the doctor that they are using everolimus. Doctors may adjust the treatment plan based on the patient's specific situation to reduce side effects and improve treatment effectiveness. At the same time, patients should avoid taking drugs or foods that may increase the risk of side effects while taking everolimus, and undergo regular examinations to monitor their physical condition.

All in all, everolimus is a prescription drug and must be used strictly in accordance with the doctor's instructions. If you have any questions or symptoms, please communicate with your doctor immediately. Currently, everolimus has both original research version and affordable Indian generic version. Patients should choose by themselves, but be sure to purchase it through formal channels.